Novartis AG Sponsored ADR (NVSN)
BMV
Closed
Aug 21, 2026
Day's Range
2,677.0052 wk Range
2,206.00Overview - NVSN - Novartis AG Sponsored ADR
Key Statistics
Valuation
Enterprise Value
87.51T
P/E (Trailing)
‪23.69‬
PEG Ratio
‪-1.36‬
Price / Sales (TTM)
‪89.75‬
Price / Book
‪7.19‬
EV / EBITDA
‪222.09‬
Profitability
Gross Margin
‪75.18%‬
Profit Margin
‪22.50%‬
Operating Margin
‪34.62%‬
Return on Assets
‪10.25%‬
Return on Equity
‪30.35%‬
Ownership
Shares Outstanding
1.90B
Float
1.85B
Held by Insiders
‪0.01%‬
Held by Institutions
‪7.26%‬
Price stats
Beta
‪0.49‬
50-Day Avg
‪2,686.84‬
200-Day Avg
‪2,622.12‬
Dividends
Payout Ratio
‪71.59%‬
Frequency
Annual
Market Cap - NVSN - Novartis AG Sponsored ADR
Peers - NVSN - Novartis AG Sponsored ADR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BMV.
Profile Summary - NVSN - Novartis AG Sponsored ADR
About
Novartis AG Sponsored ADR represents ownership in Novartis AG, a global healthcare company focused on researching, developing, manufacturing, and marketing innovative medicines. Through this ADR structure, U.S. investors can gain exposure to Novartis AG shares in U.S. dollars, with each depositary receipt backed by an…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
